{{Drugbox
| verifiedrevid = 444137594
| IUPAC_name        = 4-Phenyl-N-(2-phenylethyl)-1,3-thiazol-2-amine
| image = Fanetizole structure.png
<!--Clinical data-->
| tradename =  
| licence_US =  
| pregnancy_AU =  
| legal_AU =  
| legal_UK =  
| legal_US =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound = %
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| CAS_number        = 79069-94-6
| ATC_prefix =  
| ATC_suffix =  
| ATC_supplemental =  
| PubChem = 54339
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID      = 49083
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = BH48F620JA
<!--Chemical data-->
| C=17 | H=16 | N=2 | S=1
| molecular_weight = 280.39 g/mol
| smiles            = n1c(csc1NCCc2ccccc2)c3ccccc3
| StdInChI          = 1S/C17H16N2S/c1-3-7-14(8-4-1)11-12-18-17-19-16(13-20-17)15-9-5-2-6-10-15/h1-10,13H,11-12H2,(H,18,19)
| StdInChIKey       = WEEYMMXMBFJUAI-UHFFFAOYSA-N
}}

'''Fanetizole''' shows immunoregulating activity.

==Synthesis==
[[Thiourea]]s serve as a convenient starting material for 2-aminothiazoles. 
[[File:Fanetizole synthesis.svg|700px|thumb|center|Fanetizole synthesis:<ref>Lombardino, J. G.; 1981, {{US Patent|4,307,106}}</ref>]]
Reaction of Î²-[[phenethylamine]] with [[ammonium isothiocyanate]] gives the [[thiourea]] ('''2''') Treatment of that product with [[phenacyl bromide]] thus affords the thiazole product.

==References==
{{Reflist}}

{{Histaminergics}}
{{H2-receptor antagonist}}

[[Category:H2 receptor antagonists]]
[[Category:Thiazoles]]